Very early researchNot Yet RecruitingNCT07671417What this trial is testingImaging Study in Metastatic Clear Cell RCC.Who this might be right forMetastatic Clear Cell Renal Cell Carcinoma RayzeBio, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT03428217What this trial is testingCANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell CarcinomaWho this might be right forAdvanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma Calithera Biosciences, Inc 444
Testing effectiveness (Phase 2)Study completedNCT00588913What this trial is testingAdoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung MetastasesWho this might be right forKidney CancerMetastatic Cancer Tokyo Women's Medical University 20
Not applicableStudy completedNCT04415697What this trial is testingIdentification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal CarcinomasWho this might be right forKidney CancerBiomarkersGene Expression Barretos Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01108445What this trial is testingPhase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced Non-clear Cell Renal Cell Carcinoma Duke University 131
Testing effectiveness (Phase 2)Looking for participantsNCT07123090What this trial is testingSasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell CarcinomaMetastatic Renal CancerRenal Cell Carcinoma+3 more Stephanie Berg 25
Early research (Phase 1)Active Not RecruitingNCT03354390What this trial is testingHERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forKidney Cancer National Heart, Lung, and Blood Institute (NHLBI) 17
Testing effectiveness (Phase 2)Ended earlyNCT00126659What this trial is testingSorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05831891What this trial is testingFruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell CarcinomaWho this might be right forNon-clear Cell Renal Cell Carcinoma RenJi Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00278174What this trial is testingInterferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney CancerWho this might be right forKidney Cancer Case Comprehensive Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT01693822What this trial is testingA Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for NephrectomyWho this might be right forClear-cell Metastatic Renal Cell Carcinoma Institute of Cancer Research, United Kingdom 65
Early research (Phase 1)Ended earlyNCT02386111What this trial is testingVarlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forCarcinoma, Renal CellKidney DiseasesKidney Neoplasms+6 more Celldex Therapeutics 17
Early research (Phase 1)Looking for participantsNCT06242470What this trial is testingMGC026 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorAdvanced CancerMetastatic Cancer+19 more MacroGenics 250
Testing effectiveness (Phase 2)Study completedNCT02819596What this trial is testingMEDI4736 Combinations in Metastatic Renal Cell CarcinomaWho this might be right forRenal Clear Cell CarcinomaRenal Papillary Cell Carcinoma Queen Mary University of London 69
Early research (Phase 1)Looking for participantsNCT04777994What this trial is testingStudy With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsWho this might be right forAdvanced Solid Tumor Cancer Calico Life Sciences LLC 248
Testing effectiveness (Phase 2)WithdrawnNCT03035630What this trial is testingSunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell CarcinomaWho this might be right forClear-cell Renal Cell CarcinomaRCCKidney Cancer+1 more Guru Sonpavde
Not applicableStudy completedNCT00253383What this trial is testingEarly Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsWho this might be right forCancer Dartmouth-Hitchcock Medical Center 329
Not applicableLooking for participantsNCT04623502What this trial is testingAn Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or BiopsyWho this might be right forKidney CancerRenal Cell CarcinomaClear Cell Carcinoma+9 more University of Texas Southwestern Medical Center 600
Testing effectiveness (Phase 2)Ended earlyNCT06716853What this trial is testingA Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell CarcinomaWho this might be right forClear Cell RCC Genenta Science 10
Testing effectiveness (Phase 2)Study completedNCT00126594What this trial is testingSorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer National Cancer Institute (NCI) 80